HEMATOLOGIC MALIGNANCY SPECIFIC BIOMARKERS

摘要

The present invention relates to a hematologic tumor disease-specific biomarker, and since the NGAL protein level, neutrophil count and BM band neutrophil %, which are biomarkers of the present invention, change specifically for hematologic malignancies, they are used for classification and diagnosis of hematologic malignancies. Alternatively, it may be usefully used for prognostic judgment.